Related Experiment Video
Updated: Oct 23, 2025

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
Published on: July 8, 2025
Surmounting structural barriers to tackle endemic infectious diseases
Felix Calderón1, Alan H Fairlamb2, Mike Strange1,3
1Global Health Pharma Unit, GlaxoSmithKline R&D, Tres Cantos, Madrid, Spain.
Academic and industrial scientists collaborated successfully to combat infectious diseases. This unique partnership model, fostering innovation in drug discovery, has proven effective over ten years.
Area of Science:
- * Infectious disease research and drug discovery.
- * Public-private partnerships in scientific innovation.
Background:
- * Endemic infectious diseases pose significant global health challenges.
- * Traditional research models face limitations in addressing these complex diseases.
- * The need for innovative collaborative frameworks between academia and industry.
Purpose of the Study:
- * To evaluate the success of a unique academic-industrial collaboration model.
- * To assess the model's impact on tackling tuberculosis, protozoal infections, and enteric bacterial diseases.
- * To highlight the distinctive features and sustainability of the Tres Cantos Open Lab Foundation.
Main Methods:
- * Funding extended stays for academic scientists at a pharmaceutical company campus.
- * Facilitating resource access and collaborative research between academics and industry scientists.
- * Guided by independent experts and a foundation structure.
Main Results:
- * Demonstrated success in advancing research on tuberculosis, protozoal infections, and enteric bacterial diseases.
- * Sustained progress over a decade, indicating model efficacy and adaptability.
- * Established a unique model complementing existing public-private partnerships.
Conclusions:
- * The Tres Cantos Open Lab Foundation model is a successful strategy for academic-industrial collaboration.
- * This approach effectively accelerates progress against critical infectious diseases.
- * The model offers valuable insights for developing future public-private research partnerships.
Related Concept Videos
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Principles of Disease Surveillance
Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
Development of Antibiotic Resistance
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

